High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDE

article

High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDE is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1107406011
P356DOI10.1007/S10461-018-2290-3
P698PubMed publication ID30284653

P50authorGarrett PrestageQ41676746
David J TempletonQ45413753
Rebecca GuyQ58324757
P2093author name stringAndrew Carr
Andrew E Grulich
Mark Bloch
Catriona Ooi
David Templeton
Anna McNulty
Isobel M Poynten
Iryna B Zablotska
Garrett Prestage
Rosalind Foster
Nathan Ryder
Catherine Pell
Andrew E. Grulich
Iryna B. Zablotska
Stefanie J Vaccher
Isobel M. Poynten
Stefanie J. Vaccher
P407language of work or nameEnglishQ1860
P921main subjectseroconversionQ2141450
P577publication date2018-10-04
P1433published inAIDS and BehaviorQ15752229
P1476titleHigh Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDE

Reverse relations

cites work (P2860)
Q89613721Can gut microbiota of men who have sex with men influence HIV transmission?
Q92062770Facilitating engagement with PrEP and other HIV prevention technologies through practice-based combination prevention
Q91583474Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis

Search more.